1. The Birth of a Field
In the early 2010s, a small New Jersey company called ElectroCore did something radical - it made vagus nerve stimulation non-invasive. For decades, VNS had been confined to surgically implanted devices like LivaNova’s systems, used for treatment-resistant depression and epilepsy. These implants worked well but required surgery, carried risks, and cost thousands.
ElectroCore’s handheld device, later branded as GammaCore, changed that. By applying electrical current to the neck - targeting the cervical branch of the vagus nerve - they created the first commercially viable non-invasive vagus nerve stimulator (niVNS). It proved effective for acute migraine and cluster headache, earning multiple FDA clearances and setting the foundation for modern neuromodulation.
In many ways, ElectroCore founded the non-invasive VNS field. Their engineering rigor and clinical persistence turned a fringe idea into an accepted therapeutic category.
As their technology matured, ElectroCore extended its reach beyond the medical domain:
- TruVaga, their wellness-oriented spinoff, adapted the same cervical stimulation platform for stress relief and resilience training.
- TAC-STIM, developed in collaboration with the U.S. Department of Defense, tailored the same core stimulation principles toward cognitive enhancement and stress regulation for military and performance settings.
And more recently, the company released TruVaga Plus, a version that no longer relies on the monthly activation subscription model. That shift - from consumable billing to durable ownership - marks a meaningful step forward for accessibility and user autonomy. At ZenBud, we genuinely applaud this move. Subscription-based treatment models often restrict access and reinforce dependence. The shift toward durable ownership is a welcome correction in the right direction.
2. A New Modality: The Rise of Ultrasound Neuromodulation
A decade after ElectroCore’s breakthrough, a new modality entered the field - ultrasound-based vagus nerve stimulation (uVNS). Unlike electrical current, ultrasound modulates neural activity through precise mechanical pressure waves.
This is the foundation of ZenBud.
Ultrasound can penetrate deeper tissues and interact with the nerve through mechanosensitive ion channels rather than direct ionic depolarization. In other words, it speaks the nervous system’s language of pressure instead of electricity.
Peer-reviewed data published in JMIR Neuro (2025) showed 78.6% remission in clinically anxious participants after four weeks of daily ZenBud use - a rate exceeding those reported for SSRIs, talk therapy, or existing non-invasive stimulators. Early yet promising, the results suggest that ultrasound may offer both high efficacy and superior comfort, a combination rarely achieved in neuromodulation.
3. The Method Matters: Electrical vs. Ultrasound
| Aspect | GammaCore / TruVaga / TAC-STIM | ZenBud |
|---|---|---|
| Energy Type | Electrical current | Ultrasound (mechanical pressure waves) |
| Mechanism | Depolarizes neurons via ionic current | Modulates mechanosensitive ion channels acoustically |
| User Sensation | Tingling or mild shock | Gentle hum, no discomfort |
| Precision | Surface-limited, current-based | Deep, focusable, tissue-tuned |
| Comfort | Requires tolerance | Comfortable from first use |
Electrical stimulation requires current strong enough to overcome skin impedance, leading to the characteristic “zap” sensation users often describe. It works, but it can deter consistent use. Ultrasound, by contrast, travels efficiently through tissue with no shock or pain - stimulating the nerve through micro-mechanical pressure instead of electricity.
That physical difference matters: it changes the nerve fibers being activated. Electrical cervical VNS primarily recruits A- and B-fibers, while ultrasound can reach deeper, slower C-fibers associated with parasympathetic tone and anti-stress signaling.
4. Where You Stimulate Matters: Cervical vs. Auricular
The vagus nerve isn’t a single cable - it’s an entire network of highways. Where you stimulate determines which biological systems you affect.
Cervical stimulation, used by GammaCore, TruVaga, and TAC-STIM, targets the main nerve trunk in the neck. This branch regulates visceral organs, cardiovascular tone, and inflammation. It’s powerful but must be applied carefully to avoid unwanted cardiac or blood pressure effects.
Auricular stimulation, ZenBud’s target, accesses a smaller branch that connects directly to the nucleus tractus solitarius (NTS) - the brainstem hub for autonomic regulation, emotional balance, and interoception. Research has shown auricular stimulation can enhance heart-rate variability (HRV), lower cortisol, and modulate brain networks involved in anxiety and emotional control - all without the cardiac risks of cervical stimulation.
Put simply:
- Cervical = systemic and strong, ideal for pain and medical conditions.
- Auricular = precise and subtle, ideal for emotional and autonomic regulation.
5. The User Experience Divide
ElectroCore’s early commercial design reflected its medical DNA: handheld, gel-dependent, and cartridge-based. GammaCore users replace a proprietary cartridge each month, a model originally designed to fit insurance billing and treatment cycles.
TruVaga Plus represents a welcome evolution - eliminating the subscription model, simplifying access, and reducing cost barriers. It’s a rare and commendable example of a medical pioneer listening to users and iterating toward freedom, not dependency.
ZenBud, meanwhile, was designed from day one as a wearable rather than a handheld. Its gel-free silicone interface and durable build make it frictionless for daily use - just five minutes a day, hands-free. The design philosophy centers on restoration, not repeat monetization.
Both companies are solving the same problem from different angles: one through medical evolution, the other through human-centered design.
6. Clinical and Philosophical Divergence
ElectroCore’s strength lies in scale and rigor. They’ve conducted hundreds of clinical studies, secured multiple FDA clearances, and gathered extensive safety data. Their devices have been tested in headaches, asthma, epilepsy adjuncts, and stress. That institutional credibility can’t be overstated.
ZenBud, by contrast, is new - but its signal strength (in both the engineering and statistical sense) is hard to ignore.
- GammaCore and TruVaga’s stress-related efficacy: ~10–15%.
- Implanted VNS (LivaNova): ~40–45% remission in depression.
- ZenBud (ultrasound uVNS): 78.6% remission in anxiety.
While more research is underway, the implication is clear: new physics can yield new outcomes.
Philosophically, the two companies also differ.
- ElectroCore commercialized non-invasive VNS as a medical therapy - pioneering, regulated, and clinically meticulous.
- ZenBud was born from a rebellion against the “stress economy,” viewing mental health not as a market but as a human birthright to restore.
Both perspectives are necessary. One builds legitimacy; the other builds liberation.
7. Convergence and Collaboration
The future isn’t one device or the other - it’s an ecosystem of neuromodulation tools. ElectroCore’s TAC-STIM represents high-performance, situational vagal activation. TruVaga Plus offers accessible, consumer-grade cervical VNS for wellness. ZenBud extends the field into comfortable, ultrasound-based daily use.
Each tool serves a different niche on the same spectrum of self-regulation. In that sense, competition becomes collaboration. Each company refines humanity’s ability to modulate its own nervous system - to regain control over stress, emotion, and performance.
8. Toward the Next Decade
If the 2010s were about proving non-invasive VNS works, the 2020s will be about making it humane - effective, effortless, and sustainable.
Ultrasound opens new frontiers for precision and comfort. But the courage to take the first step - to make VNS handheld, safe, and accessible - belongs to ElectroCore. Without their vision, there would be no industry to evolve.
The story of GammaCore and ZenBud isn’t rivalry. It’s continuity. It’s the nervous system learning, iteration by iteration, how to heal itself.